Actionnariat et activité des initiés pour Harmony Biosciences Holdings, Inc. (HRMY): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $42.21 |
| Capitalisation | $2.4B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-08 | Budur Kumar | M-Exempt | 10,754 | $326K |
| 2026-09-08 | Budur Kumar | M-Exempt | 10,754 | $326K |
| 2026-09-08 | Budur Kumar | M-Exempt | 12,200 | $374K |
| 2026-09-08 | Budur Kumar | M-Exempt | 12,200 | $374K |
| 2026-09-04 | Budur Kumar | S-Sale | 5,500 | $231K |
| 2026-09-08 | Budur Kumar | S-Sale | 4,500 | $190K |
| 2026-09-08 | Budur Kumar | S-Sale | 1,000 | $43K |
| 2026-09-08 | Budur Kumar | S-Sale | 22,954 | $989K |
| 2026-07-16 | Mollichella Stephen M. | |||
| 2026-07-16 | Mollichella Stephen M. | 20,750 | $763K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $83.5M | $24.5M | $228.6M | $234.3M | $243.8M | $311.7M | $453.0M | $752.5M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | $79.3M | $41.8M | $14.2M | $22.8M |
| Créances | 0 | $4.3M | $22.2M | $34.8M | $54.7M | $74.1M | $83.0M | $96.8M |
| Stocks | 0 | $1.1M | $3.8M | $4.4M | $4.3M | $5.4M | $7.2M | $5.4M |
| Actifs Courants | $86.7M | $31.5M | $262.9M | $284.4M | $400.3M | $451.1M | $579.3M | $907.0M |
| Immobilisations Corporelles | $1.6M | $1.3M | $938000 | $4.1M | $573000 | $371000 | $3.4M | $5.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | $72.2M | $162.3M | $143.9M | $161.0M | $137.1M | $113.3M | $89.4M |
| Actifs Totaux | $89.3M | $106.7M | $427.1M | $433.4M | $673.9M | $811.4M | $999.2M | $1.27B |
| Dettes Fournisseurs | $1.5M | $6.4M | $2.6M | $1.0M | $3.8M | $17.7M | $13.7M | $17.7M |
| Dette à Court Terme | 0 | 0 | 0 | $2.0M | $2.0M | $15.0M | $16.2M | $86.9M |
| Passifs Courants | $7.2M | $19.9M | $134.5M | $53.8M | $78.9M | $163.8M | $175.1M | $252.1M |
| Dette à Long Terme | $324.2M | $97.9M | $194.2M | $190.0M | $189.6M | $178.6M | $163.0M | $148.2M |
| Passifs Totaux | $7.8M | $118.3M | $329.9M | $246.9M | $271.0M | $344.5M | $340.0M | $401.4M |
| Réserves | -$242.7M | -$422.9M | -$488.2M | -$453.6M | -$272.1M | -$143.3M | $2.2M | $160.9M |
| Capitaux Propres | $81.5M | -$11.6M | $97.2M | $186.5M | $402.8M | $467.0M | $659.2M | $870.2M |
| Dette Totale | $324.2M | $97.9M | $194.2M | $195.7M | $191.6M | $193.6M | $181.4M | $239.6M |
| Dette Nette | $240.7M | $73.5M | -$34.4M | -$38.6M | -$131.5M | -$159.9M | -$285.8M | -$535.8M |
| Fonds de Roulement | $79.5M | $11.6M | $128.4M | $230.7M | $321.4M | $287.3M | $404.2M | $654.9M |
Santé financière
| Dette / Capitaux propres | 0.15 |
| Ratio de liquidité | 3.48 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 5.23 |
Rentabilité
| Rentabilité des capitaux propres | 20.06% |
| Rentabilité du capital investi | 14.96% |
| Rentabilité des actifs | 13.20% |
| Marge brute | 75.42% |
| Marge opérationnelle | 24.03% |
| Marge nette | 18.88% |
Entreprises liées: ABCL · AUPH · BHVN · CLDX · IMCR · JANX · MNKD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de HRMY: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions